1. Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
   Diego Estrada-Luna et al, 2018, Molecules CrossRef
2. Improving the bioavailability and therapeutic efficacy of felodipine for the control of diabetes-associated atherosclerosis: In vitro and in vivo characterization
   Dina M. Mahmoud et al, 2024, International Journal of Pharmaceutics CrossRef
3. Association of Circulating Levels of ADMA with Carotid Intima-Media Thickness in Patients with CKD: a Systematic Review and Meta-Analysis
   Fang Wang et al, 2018, Kidney and Blood Pressure Research CrossRef
4. Ocular delivery of felodipine for the management of intraocular pressure and inflammation: Effect of film plasticizer and in vitro in vivo evaluation
   Rakesh Swain et al, 2023, International Journal of Pharmaceutics CrossRef
5. MiR-410 inhibition induces HUVECs proliferation and represses ox-LDL-triggered apoptosis through activating STAT3
   Ming-Yan Hu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
6. Co-expression network analysis reveals the pivotal role of mitochondrial dysfunction and interferon signature in juvenile dermatomyositis
   Danli Zhong et al, 2020, PeerJ CrossRef
7. Effect of felodipine on indomethacin-induced gastric ulcers in rats
   Nergis Akbaş et al, 2023, Experimental Animals CrossRef
8. Interference with lysophosphatidic acid receptor 5 ameliorates oxidized low-density lipoprotein-induced human umbilical vein endothelial cell injury by inactivating NOD-like receptor family, pyrin domain containing 3 inflammasome signaling
   Ling Xu et al, 2021, Bioengineered CrossRef
9. Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy
   Ye Chen et al, 2022, Biomedicine & Pharmacotherapy CrossRef
10. PRMT5 knockdown enhances cell viability and suppresses cell apoptosis, oxidative stress, inflammation and endothelial dysfunction in ox-LDL-induced vascular endothelial cells via interacting with PDCD4
    Xiaohong Fei et al, 2023, International Immunopharmacology CrossRef
11. Focal Adhesion Kinase Inhibitor Inhibits the Oxidative Damage Induced by Central Venous Catheter via Abolishing Focal Adhesion Kinase-Protein Kinase B Pathway Activation
    Yanru Wang et al, 2021, BioMed Research International CrossRef
12. Immunomodulatory properties of antihypertensive drugs and digitalis glycosides
    Paweł Bryniarski et al, 2022, Expert Review of Cardiovascular Therapy CrossRef